Eligibility & Dose Requirements Proof of your current prescription and dosage is required during your consultation. Your provider will verify your eligibility and determine the appropriate dose based on your treatment history. To qualify for 4.4mg/week, you must have been prescribed at least 2.2mg/week within the past 45 days. To qualify for 7mg/week, you must have been prescribed at least 4.4mg/week within the past 45 days. To qualify for 10mg/week, you must have been prescribed at least 7mg/week within the past 45 days. Patients requesting 13mg/week must have documentation of prior treatment at an appropriate dose, as determined by the prescribing provider
NNMT (nicotinamide N-methyltransferase) is the enzyme 5-Amino-1MQ inhibits, and tissue expression varies significantly across organs: adipose tissue shows 812 higher NNMT activity than skeletal muscle, which is why subcutaneous injection near adipose depots produces localised effects rodent models couldn't predict
Overall, GHK-Cu shows promise in various applications, from skincare to potential medical therapies
One concerned orthopedic doctor wrote a summary on the potential connection between BPC 157 and cancer that is eye opening and suggests that the way BPC 157 works to heal by creating new blood supplies could also create new blood supplies for tumors
doi: 10.1073/pnas.1207169109 116 GoreACThompsonLMBellMMennigenJA